IL6 and IL8 have been identified as direct CEBPB and CEBPD targets [48,49], and there is evidence that cancer-cell-derived IL-6 and IL-8 promote tumor growth and metastasis and therapeutic resistance [50,51]. Here, CEBPD is linked to cancer.